Literature DB >> 22942426

Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction.

Gaetano Zizzo1, Brendan A Hilliard, Marc Monestier, Philip L Cohen.   

Abstract

Mer tyrosine kinase (MerTK) is a major macrophage apoptotic cell (AC) receptor. Its functional impairment promotes autoimmunity and atherosclerosis, whereas overexpression correlates with poor prognosis in cancer. However, little is known about mechanisms regulating MerTK expression in humans. We found that MerTK expression is heterogenous among macrophage subsets, being mostly restricted to anti-inflammatory M2c (CD14(+)CD16(+)CD163(+)CD204(+)CD206(+)CD209(-)) cells, differentiated by M-CSF or glucocorticoids. Small numbers of MerTK(+) "M2c-like" cells are also detectable among circulating CD14(bright)CD16(+) monocytes. MerTK expression levels adapt to changing immunologic environment, being suppressed in M1 and M2a macrophages and in dendritic cells. Remarkably, although glucocorticoid-induced differentiation is IL-10 independent, M-CSF-driven M2c polarization and related MerTK upregulation require IL-10. However, neither IL-10 alone nor TGF-β are sufficient to fully differentiate M2c (CD16(+)CD163(+)MerTK(+)) macrophages. M-CSF and IL-10, both released by T lymphocytes, may thus be required together to promote regulatory T cell-mediated induction of anti-inflammatory monocytes-macrophages. MerTK enables M2c macrophages to clear early ACs more efficiently than other macrophage subsets, and it mediates AC clearance by CD14(bright)CD16(+) monocytes. Moreover, M2c cells release Gas6, which in turn amplifies IL-10 secretion via MerTK. IL-10-dependent induction of the Gas6/MerTK pathway may, therefore, constitute a positive loop for M2c macrophage homeostasis and a critical checkpoint for maintenance of anti-inflammatory conditions. Our findings give new insight into human macrophage polarization and favor a central role for MerTK in regulation of macrophage functions. Eliciting M2c polarization can have therapeutic utility for diseases such as lupus, in which a defective AC clearance contributes to initiate and perpetuate the pathological process.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22942426      PMCID: PMC3465703          DOI: 10.4049/jimmunol.1200662

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

Review 1.  Clearance of apoptotic and necrotic cells and its immunological consequences.

Authors:  Dmitri V Krysko; Katharina D'Herde; Peter Vandenabeele
Journal:  Apoptosis       Date:  2006-10       Impact factor: 4.677

2.  Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression.

Authors:  Fernando O Martinez; Siamon Gordon; Massimo Locati; Alberto Mantovani
Journal:  J Immunol       Date:  2006-11-15       Impact factor: 5.422

3.  Immunosuppressive effects of apoptotic cells.

Authors:  R E Voll; M Herrmann; E A Roth; C Stach; J R Kalden; I Girkontaite
Journal:  Nature       Date:  1997-11-27       Impact factor: 49.962

4.  A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock.

Authors:  T D Camenisch; B H Koller; H S Earp; G K Matsushima
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

Review 5.  The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes.

Authors:  R P Donnelly; H Dickensheets; D S Finbloom
Journal:  J Interferon Cytokine Res       Date:  1999-06       Impact factor: 2.607

6.  Effects of high-dose methylprednisolone therapy on coagulation factors in patients with acute immune thrombocytopenic purpura.

Authors:  Ahmet Faik Oner; Ali Bay; Mehmet Kuru; Abdurrahman Uner; Sukru Arslan; Hüseyin Caksen
Journal:  Clin Appl Thromb Hemost       Date:  2005-10       Impact factor: 2.389

7.  A role for Mer tyrosine kinase in alphavbeta5 integrin-mediated phagocytosis of apoptotic cells.

Authors:  Yi Wu; Sukhwinder Singh; Maria-Magdalena Georgescu; Raymond B Birge
Journal:  J Cell Sci       Date:  2005-02-01       Impact factor: 5.285

8.  Human macrophages induced in vitro by macrophage colony-stimulating factor are deficient in IL-12 production.

Authors:  W Smith; M Feldmann; M Londei
Journal:  Eur J Immunol       Date:  1998-08       Impact factor: 5.532

9.  IL-10-producing macrophages preferentially clear early apoptotic cells.

Authors:  Wei Xu; Anja Roos; Nicole Schlagwein; Andrea M Woltman; Mohamed R Daha; Cees van Kooten
Journal:  Blood       Date:  2006-02-23       Impact factor: 22.113

10.  IL-10 stimulates monocyte Fc gamma R surface expression and cytotoxic activity. Distinct regulation of antibody-dependent cellular cytotoxicity by IFN-gamma, IL-4, and IL-10.

Authors:  A A te Velde; R de Waal Malefijt; R J Huijbens; J E de Vries; C G Figdor
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

View more
  229 in total

Review 1.  Macrophage subsets in atherosclerosis.

Authors:  Giulia Chinetti-Gbaguidi; Sophie Colin; Bart Staels
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

Review 2.  Macrophages in atherosclerosis: a dynamic balance.

Authors:  Kathryn J Moore; Frederick J Sheedy; Edward A Fisher
Journal:  Nat Rev Immunol       Date:  2013-09-02       Impact factor: 53.106

Review 3.  Monocytes and macrophages in abdominal aortic aneurysm.

Authors:  Juliette Raffort; Fabien Lareyre; Marc Clément; Réda Hassen-Khodja; Giulia Chinetti; Ziad Mallat
Journal:  Nat Rev Cardiol       Date:  2017-04-13       Impact factor: 32.419

4.  HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness.

Authors:  David Kuo; Jennifer Ding; Ian S Cohn; Fan Zhang; Kevin Wei; Deepak A Rao; Cristina Rozo; Upneet K Sokhi; Sara Shanaj; David J Oliver; Adriana P Echeverria; Edward F DiCarlo; Michael B Brenner; Vivian P Bykerk; Susan M Goodman; Soumya Raychaudhuri; Gunnar Rätsch; Lionel B Ivashkiv; Laura T Donlin
Journal:  Sci Transl Med       Date:  2019-05-08       Impact factor: 17.956

Review 5.  Scavenger receptors in homeostasis and immunity.

Authors:  Johnathan Canton; Dante Neculai; Sergio Grinstein
Journal:  Nat Rev Immunol       Date:  2013-08-09       Impact factor: 53.106

6.  A Janus role for MerTK in the outcome of septic shock.

Authors:  Massimo Girardis; Andrea Cossarizza
Journal:  Intensive Care Med       Date:  2013-10-03       Impact factor: 17.440

7.  Tumor-secreted Pros1 inhibits macrophage M1 polarization to reduce antitumor immune response.

Authors:  Eric Ubil; Laura Caskey; Alisha Holtzhausen; Debra Hunter; Charlotte Story; H Shelton Earp
Journal:  J Clin Invest       Date:  2018-04-30       Impact factor: 14.808

Review 8.  Minireview: Emerging Concepts in Islet Macrophage Biology in Type 2 Diabetes.

Authors:  David L Morris
Journal:  Mol Endocrinol       Date:  2015-05-22

9.  Triple Therapy with MerTK and PD1 Inhibition Plus Radiotherapy Promotes Abscopal Antitumor Immune Responses.

Authors:  Mauricio S Caetano; Ahmed I Younes; Hampartsoum B Barsoumian; Michael Quigley; Hari Menon; Chan Gao; Thomas Spires; Timothy P Reilly; Alexandra P Cadena; Taylor R Cushman; Jonathan E Schoenhals; Ailin Li; Quynh-Nhu Nguyen; Maria Angelica Cortez; James W Welsh
Journal:  Clin Cancer Res       Date:  2019-09-20       Impact factor: 12.531

Review 10.  Delta-Like Ligand 4-Notch Signaling in Macrophage Activation.

Authors:  Toshiaki Nakano; Daiju Fukuda; Jun-Ichiro Koga; Masanori Aikawa
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-08-25       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.